Description
Seeking men 18 years of age or older, for participation in a study of an investigational drug called Relugolix in combination with other drugs, for certain types of prostate cancer.
Overview
We are studying the effects of Relugolix in combination with other drugs, to determine how safe and how well these work in participants with certain types of prostate cancer.
What we're hoping for
To determine whether relugolix, in combination with other approved drugs is safe and well tolerated for the treatment of patients with certain types of prostate cancer.
Additional Information
ClinicalTrials.gov Identifier: NCT04666129